Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1991 Jan;63(1):6–8. doi: 10.1038/bjc.1991.3

Synthetic oligonucleotides as therapeutic agents.

D M Tidd
PMCID: PMC1971642  PMID: 1989666

Full text

PDF
8

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertrand J. R., Rayner B., Imbach J. L., Paoletti C., Malvy C. Comparative activity of alpha- and beta-anomeric oligonucleotides on rabbit beta globin synthesis: inhibitory effect of cap targeted alpha-oligonucleotides. Biochem Biophys Res Commun. 1989 Oct 16;164(1):311–318. doi: 10.1016/0006-291x(89)91719-1. [DOI] [PubMed] [Google Scholar]
  2. Cooney M., Czernuszewicz G., Postel E. H., Flint S. J., Hogan M. E. Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science. 1988 Jul 22;241(4864):456–459. doi: 10.1126/science.3293213. [DOI] [PubMed] [Google Scholar]
  3. Kibler-Herzog L., Kell B., Zon G., Shinozuka K., Mizan S., Wilson W. D. Sequence dependent effects in methylphosphonate deoxyribonucleotide double and triple helical complexes. Nucleic Acids Res. 1990 Jun 25;18(12):3545–3555. doi: 10.1093/nar/18.12.3545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Klausner A. Antisense start-ups surveyed. Biotechnology (N Y) 1990 Apr;8(4):303–304. doi: 10.1038/nbt0490-303. [DOI] [PubMed] [Google Scholar]
  5. McManaway M. E., Neckers L. M., Loke S. L., al-Nasser A. A., Redner R. L., Shiramizu B. T., Goldschmidts W. L., Huber B. E., Bhatia K., Magrath I. T. Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. Lancet. 1990 Apr 7;335(8693):808–811. doi: 10.1016/0140-6736(90)90934-w. [DOI] [PubMed] [Google Scholar]
  6. Miller P. S., Ts'o P. O. A new approach to chemotherapy based on molecular biology and nucleic acid chemistry: Matagen (masking tape for gene expression). Anticancer Drug Des. 1987 Oct;2(2):117–128. [PubMed] [Google Scholar]
  7. Tidd D. M., Warenius H. M. Partial protection of oncogene, anti-sense oligodeoxynucleotides against serum nuclease degradation using terminal methylphosphonate groups. Br J Cancer. 1989 Sep;60(3):343–350. doi: 10.1038/bjc.1989.283. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES